EUVIMEDEUVIMED entdecken
Crossref

Chemotherapy Effectiveness in Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer after Third-Line or Later Treatment: An Overtreatment Concern in Everyday Clinical Practice

Mustafa Ersoy

Lokman Hekim Health Sciences · 2026 · 458-465

DOI: 10.14744/lhhs.2026.02303 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Lokman Hekim Health Sciences, 2026. Verfasst von Mustafa Ersoy.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Ersoy, M. (2026). Chemotherapy Effectiveness in Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer after Third-Line or Later Treatment: An Overtreatment Concern in Everyday Clinical Practice. Lokman Hekim Health Sciences, 458-465. https://doi.org/10.14744/lhhs.2026.02303

Vancouver

Ersoy M. Chemotherapy Effectiveness in Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer after Third-Line or Later Treatment: An Overtreatment Concern in Everyday Clinical Practice. Lokman Hekim Health Sciences. 2026:458-465. doi:10.14744/lhhs.2026.02303

BibTeX
@article{Ersoy2026,
  author = {Ersoy, Mustafa},
  title = {Chemotherapy Effectiveness in Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer after Third-Line or Later Treatment: An Overtreatment Concern in Everyday Clinical Practice},
  journal = {Lokman Hekim Health Sciences},
  year = {2026},
  pages = {458--465},
  doi = {10.14744/lhhs.2026.02303}
}
Kostenlos starten →